AI assistant
IMUGENE LIMITED — Capital/Financing Update 2022
Jun 7, 2022
65124_rns_2022-06-07_0e12e181-3f7a-4f1f-bf62-4ae56dc78f80.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [117 x 42] intentionally omitted <==
8 June 2022
ASX ANNOUNCEMENT
ASX: IMU
Notice Under Section 708A(5)(e) of the Corporations Act 2001
| Type | Shares | |
|---|---|---|
| Class/description | Ordinary | |
| ASX code | IMU | |
| Date of issue | 7 June 2022 | 8 June 2022 |
| Number issued & | 10,000,000 | 6,250,000 |
| Issue price per security | @ $0.045 ea. | @ $0.04 ea. |
| Shares issued upon the exercise of unlisted options |
Imugene Limited (ASX: IMU) (‘IMU’ or the ‘Company’) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the "Corporations Act") that:
-
the abovementioned ordinary shares were issued without disclosure under Part 6D.2 of the Corporations Act;
-
as at the date of this notice the Company has complied with:
-
(i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and
-
(ii) sections 674 and 674A of the Corporations Act; and
-
as at the date of this notice there is no "excluded information" (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company.
Nathan Jong Joint Company Secretary
IMUGENE LIMITED ACN 009 179 551
WWW.IMUGENE.COM